Table 1.
Study | Primers used for PCR | Area of brain sample | HSV-1 DNA-positive individuals | |
AD n (%) | Controls n (%) | |||
Jamieson et al. [4] | TK | Temp, frontal cortex, hippocampus | 8 (100) | 6 (100) |
Jamieson et al. [42] | TK | Temp, frontal cortex, hippocampus | 21 (67) | 15 (60) |
Baringer and Pisani [271] | Various | Various | NR | 40 (35) |
Gordon et al. [272] | Various | Hippocampus and frontal cortex | 30 (27) | |
Itabashi et al. [45] | gD | Temporal and frontal cortex | 46 (30) | 23 (22) |
Itzhaki et al. [49] | TK | Frontal and temporal cortex | 46 (67) | 44 (64) |
Lin et al. [50] | TK | Frontal and temporal cortex | 61 (74) | 48 (63) |
Bertrand et al. [273] | gD | Various | 98 (75) | 57 (72) |
Cheon et al. [274] | gD | Frontal cortex | 10 (100) | 10 (100) |
HSV-1, herpes simples virus type 1; AD, Alzheimer’s disease; PCR, polymerase chain reaction; gD, glycoprotein D protein; TK, thymidine kinase; NR, not Reported. Table adapted from Itzhaki R (2004) Herpes simplex virus type 1, apolipoprotein E and Alzheimer’ disease. Herpes 11(Suppl 2), 77A-82A. [41] Reprinted with permission from Ruth Itzhaki.